Reuters

Amylin, Lilly diabetes drug falls short of Novo's

NEW YORK, March 3 (Reuters) - A long-awaited experimental diabetes medicine from Eli Lilly & Co and Amylin Pharmaceuticals Inc , that patients need to inject only once a week, failed to match a rival ...
Reuters

Amylin, Lilly diabetes drug falls short of Novo's

NEW YORK (Reuters) - A long-awaited experimental diabetes medicine from Eli Lilly & Co and Amylin Pharmaceuticals Inc that patients need to inject only once a week failed to match up to a rival ...